Unisphere Establishment’s Boston Scientific BSX Stock Holding History

Unisphere Establishment’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$102M	Sell	2,387,800 -414,900	-15%	-$22.5M	0.87%	26
2026 Q1	$176M	Buy	2,802,700 +626,000	+29%	+$50.1M	1.48%	18
2025 Q4	$208M	Buy	2,176,700 +69,500	+3%	+$6.81M	1.55%	18
2025 Q3	$206M	Buy	2,107,200 +140,800	+7%	+$14.6M	1.61%	17
2025 Q2	$211M	Sell	1,966,400 -200,000	-9%	-$20.2M	1.7%	15
2025 Q1	$219M	Sell	2,166,400 -225,000	-9%	-$22.7M	1.91%	14
2024 Q4	$214M	Buy	2,391,400 +225,000	+10%	+$19.8M	1.86%	15
2024 Q3	$182M	Sell	2,166,400 -270,600	-11%	-$21.3M	1.72%	18
2024 Q2	$188M	Buy	2,437,000 +111,500	+5%	+$8.16M	1.89%	17
2024 Q1	$159M	Hold	2,325,500	–	–	1.61%	19
2023 Q4	$134M	Buy	+2,325,500	New	+$124M	1.39%	24

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Unisphere Establishment's BSX Position: Q2 2026 in Review

Unisphere Establishment reduced its Boston Scientific (BSX) stake by 15% in Q2 2026, selling an estimated $22.5M and leaving 2,387,800 shares worth $102M. The position accounts for 0.87% of the portfolio, ranked #26.

Unisphere Establishment first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $219M in Q1 2025. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Unisphere Establishment held 2,387,800 shares of Boston Scientific worth $102M as of Q2 2026.
Unisphere Establishment sold 414,900 Boston Scientific shares in Q2 2026, an estimated $22.5M.
Boston Scientific made up 0.87% of Unisphere Establishment's portfolio in Q2 2026, its #26 holding.
Unisphere Establishment first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Unisphere Establishment's Boston Scientific position peaked at $219M in Q1 2025.
1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Unisphere Establishment's 13F filing for Q2 2026, filed 14 Aug 2026.